BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3703282)

  • 1. Tetrahydrobiopterin in dystonia: identification of abnormal metabolism and therapeutic trials.
    LeWitt PA; Miller LP; Levine RA; Lovenberg W; Newman RP; Papavasiliou A; Rayes A; Eldridge R; Burns RS
    Neurology; 1986 Jun; 36(6):760-4. PubMed ID: 3703282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of dystonia with tetrahydrobiopterin.
    LeWitt PA; Newman RP; Miller LP; Lovenberg W; Eldridge R
    N Engl J Med; 1983 Jan; 308(3):157-8. PubMed ID: 6848912
    [No Abstract]   [Full Text] [Related]  

  • 3. Tetrahydrobiopterin administration in biopterin-deficient progressive dystonia with diurnal variation.
    Fink JK; Ravin P; Argoff CE; Levine RA; Brady RO; Hallett M; Barton NW
    Neurology; 1989 Oct; 39(10):1393-5. PubMed ID: 2477772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of tetrahydrobiopterin and 5-hydroxytryptophan on hereditary progressive dystonia with marked diurnal fluctuation: a suggestion of the serotonergic system involvement.
    Ishida A; Takada G; Kobayashi Y; Toyoshima I; Takai K
    Tohoku J Exp Med; 1988 Mar; 154(3):233-9. PubMed ID: 3259739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Striatal biopterin and tyrosine hydroxylase protein reduction in dopa-responsive dystonia.
    Furukawa Y; Nygaard TG; Gütlich M; Rajput AH; Pifl C; DiStefano L; Chang LJ; Price K; Shimadzu M; Hornykiewicz O; Haycock JW; Kish SJ
    Neurology; 1999 Sep; 53(5):1032-41. PubMed ID: 10496263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of tetrahydropterins in the treatment of hyperphenylalaninemia due to defective synthesis of tetrahydrobiopterin: evidence that peripherally administered tetrahydropterins enter the brain.
    Kaufman S; Kapatos G; McInnes RR; Schulman JD; Rizzo WB
    Pediatrics; 1982 Sep; 70(3):376-80. PubMed ID: 7110811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance of CSF biopterin and neopterin in hereditary progressive dystonia with marked diurnal fluctuation (HPD)--a clue to pathogenesis].
    Furukawa Y; Nishi K; Mizuno Y; Narabayashi H
    No To Shinkei; 1995 Mar; 47(3):261-8. PubMed ID: 7669428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical role of pteridine therapy in tetrahydrobiopterin deficiency.
    Smith I; Hyland K; Kendall B
    J Inherit Metab Dis; 1985; 8 Suppl 1():39-45. PubMed ID: 3930840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pterin abnormalities in dystonia: a metabolic marker with therapeutic implications.
    LeWitt PA; Miller LP; Levine RA; Lovenberg W; Newman RP; Papavasiliou A; Rayes A; Eldridge R; Burns RS
    Adv Neurol; 1988; 50():193-201. PubMed ID: 2456675
    [No Abstract]   [Full Text] [Related]  

  • 10. Tetrahydrobiopterin deficiencies without hyperphenylalaninemia: diagnosis and genetics of dopa-responsive dystonia and sepiapterin reductase deficiency.
    Blau N; Bonafé L; Thöny B
    Mol Genet Metab; 2001; 74(1-2):172-85. PubMed ID: 11592814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GTP-cyclohydrolase I gene mutations in hereditary progressive amd dopa-responsive dystonia.
    Furukawa Y; Shimadzu M; Rajput AH; Shimizu Y; Tagawa T; Mori H; Yokochi M; Narabayashi H; Hornykiewicz O; Mizuno Y; Kish SJ
    Ann Neurol; 1996 May; 39(5):609-17. PubMed ID: 8619546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biopterin synthesis defects: problems in diagnosis.
    Hoganson G; Berlow S; Kaufman S; Milstien S; Schuett V; Matalon R; Naylor E; Seifert W
    Pediatrics; 1984 Dec; 74(6):1004-11. PubMed ID: 6150460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biopterin and child neurologic disease].
    Shintaku H
    No To Hattatsu; 2009 Jan; 41(1):5-10. PubMed ID: 19172809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low CSF hydroxylase cofactor (tetrahydrobiopterin) levels in inherited dystonia.
    Williams A; Eldridge R; Levine R; Lovenberg W; Paulson G
    Lancet; 1979 Aug; 2(8139):410-1. PubMed ID: 89462
    [No Abstract]   [Full Text] [Related]  

  • 15. [The relation between metabolism of biopterin and dystonia-parkinsonism].
    Ichinose H; Ohye T; Suzuki T; Inagaki H; Nagatsu T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1999 Apr; 19(2):85-9. PubMed ID: 10464780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral phenylalanine loading in dopa-responsive dystonia: a possible diagnostic test.
    Hyland K; Fryburg JS; Wilson WG; Bebin EM; Arnold LA; Gunasekera RS; Jacobson RD; Rost-Ruffner E; Trugman JM
    Neurology; 1997 May; 48(5):1290-7. PubMed ID: 9153460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dopa-responsive dystonia: clinical, genetic, and biochemical studies].
    Furukawa Y
    Rinsho Shinkeigaku; 2006 Jan; 46(1):19-34. PubMed ID: 16541791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dystonia with marked diurnal variation associated with biopterin deficiency.
    Fink JK; Barton N; Cohen W; Lovenberg W; Burns RS; Hallett M
    Neurology; 1988 May; 38(5):707-11. PubMed ID: 2452381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosine hydroxylase cofactor (tetrahydrobiopterin) in parkinsonism.
    LeWitt PA; Miller LP; Newman RP; Burns RS; Insel T; Levine RA; Lovenberg W; Calne DB
    Adv Neurol; 1984; 40():459-62. PubMed ID: 6421110
    [No Abstract]   [Full Text] [Related]  

  • 20. Developmental aspects of pteridine metabolism and relationships with phenylalanine metabolism.
    Dhondt JL; Ardouin P; Hayte JM; Farriaux JP
    Clin Chim Acta; 1981 Oct; 116(2):143-52. PubMed ID: 7296883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.